CDEK
← All organizations

Seragen

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

First marketed drug

Feb 5, 1999

First NDA

Feb 5, 1999

Last known activity

Feb 5, 1999

Acquired by Ligand Pharmaceuticals on Jan 1, 1998

Timeline

1970s

  1. Jan 1, 1979

    Seragen— Founded

1990s

  1. Jan 1, 1998

    Ligand Pharmaceuticals— Acquired By

  2. Feb 5, 1999

    denileukin diftitox— NDA Organization

Indications

Approved for

Marketed drugs (1)

Details

Founded
Hopkinton, MA, US Jan 1, 1979
First NDA
Feb 5, 1999
Last known activity
Feb 5, 1999

Designations held

  • Orphan drug
  • Accelerated approval